로딩 중…
지수 로딩 중…
ADC Therapeutics S.A.
ADCT· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$1.08-2.25%
2026-06-18
Price Chart
ADC Therapeutics S.A.-64.19%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $138M |
| Revenue | $79M |
| Net Income | $-137M |
| Total Assets | $291M |
| Net Assets | $38M |
| Value | |
| P/B | 3.66x |
| P/S | 1.74x |
| FCF Yield | -83.04% |
| Profitability | |
| ROA | -47.00% |
| Op. Margin | -149.65% |
| Revenue Growth | -9.47% |
| Financial Health | |
| Debt Ratio | 1347.68% |
| Total Debt | $421M |
| FCF | $-115M |
| Cash | $231M |
| Current Ratio | 4.09x |
| Performance | |
| 1Y Return | -64.19% |
| 1M Return | -65.45% |
| From 52W High | -78.21% |
| 1Y MDD | -79.97% |
| Trading | |
| Volume | 788,012 shares |
| Trading Value | $858933.00 |
| Per Share | |
| EPS | $-0.95 |